Page last updated: 2024-08-16

pyrilamine and mdl 100907

pyrilamine has been researched along with mdl 100907 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Larrauri, JA; Levin, ED	1

Other Studies

1 other study(ies) available for pyrilamine and mdl 100907

Article	Year
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin. Psychopharmacology, 2010, Volume: 212, Issue:4 Topics: Acoustic Stimulation; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Histamine H1 Antagonists; Inhibition, Psychological; Ketanserin; Physical Stimulation; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists	2010

Article

Year

PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.

Psychopharmacology, 2010, Volume: 212, Issue:4

Topics: Acoustic Stimulation; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Histamine H1 Antagonists; Inhibition, Psychological; Ketanserin; Physical Stimulation; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists

2010